ENLVEnlivex Therapeutics Ltd.
1.470USDMkt Cap: 25.70M $P/E: 0.003d ago
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as we…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap25.70M $
Enterprise Value18.15M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)1.24B $
Revenue/Share—
Last Price1.470 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees34
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-1.88
PEG—
EV/EBITDA-1.24
EV/Revenue—
P/S—
P/B0.01
EPS (TTM)382.20
EPS (Forward)-0.78
52W Range
1.40061% of range1.515
52W High1.515 USD
52W Low1.400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE63.85%
ROA53.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.42M $
CapEx (TTM)68.00K $
FCF Margin—
FCF Yield-6758.01%
Net Debt-5.11M $
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.00
Current Ratio193.24
Quick Ratio0.69
Book Value/Sh122.27 USD
Cash/Share0.3640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 6, 2019
Splits
Last Split1:15
Split DateJul 9, 2026
Analyst Consensus
Rating—
Target (Mean)80.00 USD
Upside (mean)+5342.2%
Target Range80.00 USD – 80.00 USD
# Analysts1
Ownership
Shares Out.17.49M
Float4.82M
Insiders78.36%
Institutions1.62%
Short Interest
Short Ratio0.6d
Short % Float1.06%
Short % Out.1.05%
Shares Short177.54K
Short (prev mo.)100.76K
Technical
SMA 505.277 (-72.1%)
SMA 20011.94 (-87.7%)
Beta1.47
S&P 52W Chg19.18%
Avg Vol (30d)154.10K
Avg Vol (10d)285.68K
Technical Indicators
RSI (14)18.2
MACD-1.0636
MACD Signal-1.2463
MACD Hist.+0.1828
BB Upper3.189 USD
BB Middle2.007 USD
BB Lower0.8258 USD
BB Width117.72%
ATR (14)0.3830 USD
Vol Ratio (20d)0.33x